Anti-host cytotoxic T cells of bone marrow transplant recipients with or without graft-versus-host disease are equally sensitive to cyclosporin A

Bone Marrow Transplantation

Volumn 18, Issue 1, 1996, Pages 73-78

  Liem, L M ^a   Van Noort, J T ^a   Goulmy, E ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

CsA; CTL; GVHD; LDA

Indexed keywords

CYCLOSPORIN A;

ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE SEVERITY; DRUG SENSITIVITY; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; STEM CELL;

BONE MARROW; BONE MARROW TRANSPLANTATION; CYCLOSPORINE; CYTOTOXICITY, IMMUNOLOGIC; DRUG RESISTANCE; FEMALE; GRAFT VS HOST DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA; MALE; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0029759474     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Bortin MM, Horowitz MM, Rowlings PA et al. 1993 Progress report from the International Bone Marrow Transplant Registry. Bone Marrow Transplant 1993; 12: 97-104.
2. Beatty PG, Hervé P. Immunogenetic factors relevant to acute GVHD. In: Burakoff SJ, Deeg DHJ, Ferrara S, Atkinson K (eds). Graft-versus-Host-Disease, Immunology, Pathophysiology and Treatment. Dekker: New York, 1989, pp 415-423.
3. Martin PJ. Increased disparity for minor histocompatibility antigens as a potential cause of increased GVHD risk in marrow transplantations from unrelated donors compared with related donors. Bone Marrow Transplant 1991; 8: 217-223.
4. Goulmy E. Minor Histocompatibility antigens in man and their role in transplantation. In: Morris PJ, Tilney NL (eds). Transplantation Reviews. Saunders: Philadelphia, 1988, pp 29-53.
5. Tsoi M-S, Storb R, Dobbs S et al. Cell mediated immunity to non-HLA antigens of the host by donor lymphocytes in patients with chronic graft-versus-host disease. J Immunol 1980; 125: 2258-2262.
6. Reinsmoen NL, Kersey JH, Bach FH. Detection of HLA restricted anti minor histocompatibility antigen(s) reactive cells from skin GVHD lesions. Hum Immunol 1984; 11: 249-257.
7. Irle C, Chapuis B, Jeannet M et al. Detection of anti-non-MHC directed T cell reactivity following in vivo priming after HLA-identical marrow transplantation and following in vitro priming in limiting dilution cultures. Transplant Proc 1987; 19: 2674-2677.
8. Van Els CACM, Bakker A, Zwinderman AH et al. Effector mechanisms in graft-versus-host diease in response to minor histocompatibiliy antigens. II Evidence of a possible involvement of proliferative T cells. Transplantation 1990; 50: 67-71.
9. Guyotat D, Mauduit G, Chouvet B et al. A sequential study of histological and immunological changes in skin after allogeneic bone marrow transplantation. Transplantation 1986; 41: 340-342.
10. Kasten-Sportes C, Masset M, Varrin F et al. Phenotype and function of T lymphocytes infiltrating the skin during graft-versus-host disease following allogeneic bone marrow transplantation. Transplantation 1989; 47: 621-624.
11. Vié HP, Millpied N, Devilder MC et al. Characterization of skin-infiltrating T lymphocytes during acute graft-versus-host disease. Hum Immunol 1990; 29: 110-116.
12. Theobald M, Nierle T, Bunjes D et al. Host specific interleukin-2-secreting donor T cell precursors as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings. New Engl J Med 1992; 327: 1613-1617.
13. Schwarer AP, Jiang YZ, Brookes PA et al. Frequency of anti-recipient alloreactive helper T-cell presursors in donor blood and graft-versus-host disease after HLA-identical bone marrow transplantation. Lancet 1993; 341: 203-205.
14. Goulmy E, Gratama JW, Blokland E et al. A minor transplantation antigen detected by MHC-restricted cytotoxic T lymphocytes during graft-versus-host disease. Nature 1983; 302: 159-161.
15. Irlé C, Beatty PG, Mickelson E et al. Alloreactive T cell responses between HLA identical siblings. Transplantation 1985; 40: 329-333.
16. Van Els CACM, Bakker A, Zwinderman A et al. Effector mechanisms in graft-versus-host diease in response to minor histocompatibiliy antigens. I Absence of correlation with cytotoxic effector cells. Transplantation 1990; 50: 62-66.
17. Irschick EU, Hladik F, Niederwieser D et al. Studies on the mechanism of tolerance or graft-versus-host disease in allogeneic bone marrow recipients at the level of cytotoxic T cell precursor frequencies. Blood 1992; 79: 1622-1628.
18. Tsoi MS, Storb R, Santos E, Thomas ED. Anti-host cytotoxic cells in patients with acute graft-versus-host disease after HLA-identical marrow grafting. Transplant Proc 1983; 15: 1484-1486.
19. Niederwieser D, Grassegger A, Auböck J et al. Correlation of minor histocompatibility antigen specific cytotoxic T lymphocytes with graft-versus-host disease status and analyses of tissue distribution of their target antigens. Blood 1993, 81: 2200-2208.
20. De Bueger M, Bakker A, Bontkes H et al. High frequencies of cytotoxic T cell precursors against minor histocompatibility antigens after HLA-identical BMT. Absence of correlation with GVHD. Bone Marrow Transplant 1993; 11: 363-368.
21. Kaminski E, Sharrock C, Hows J et al. Frequency analysis of cytotoxic T lymphocyte precursors - possible relevance to HLA matched unrelated donor bone marrow transplantation. Bone Marrow Transplant 1988; 3: 149-165.
22. Francis DMA, Dumble LJ, Bowes L et al. Adverse influence of recipient lymphoid resistance to in vitro immunosuppression on the outcome of kidney transplants. Transplantation 1988; 46: 853-857.
23. Bouma GJ, Van der Meer-Prins PMW, Van Bree FPMJ et al. Determination of cytotoxic T-lymphocyte precursor frequencies using Europium labeling as a non radioactive alternative to labeling with chromium-51. Hum Immunol 1992; 35: 85-92.
24. De Bueger M, Bakker A, Goulmy E. Acquired tolerance for minor histocompatibility antigens after HLA identical bone marrow transplantation. Int Immunology 1992; 4: 53-57.
25. Strijbosch LWG, Buurman WA, Does RJMM et al. Limiting dilution assays. Experimental design and statistical analysis. J Immunol Meth 1987; 97: 133-140.
26. Bunjes D, Hardt C, Röllinghoff M, Wagner H. Cyclosporin A mediates immunosuppression of primary cytotoxic T cell response by impairng the release of interleukin 1 and interleukin 2. Eur J Immunol 1981; 11: 657-661.
27. Hess AD, Tutschka PJ, Santos GW. Effect of cyclosporin A on human lymphocyte responses in vitro. III CsA inhibits the production of T lymphocyte growth factors in secondary mixed lymphocyte responses but does not inhibit the response of primed lymphocytes to TCGF. J Immunol 1982; 128: 355-359.
28. Heeg K, Deusch K, Solbach W et al. Frequency analysis of cyclosporine-sensitive cytotoxic T lymphocyte precursors. Transplantation 1984; 38: 532-536.
29. Orosz CG, Adams PW, Ferguson RM. Frequency of human alloantigen-reactive T lymphocytes. III Evidence that cyclosporine has an inhibitory effect on human CTL and CTL precursors, independent of CsA-mediated helper T cell dysfunction. Transplantation 1988; 46: 73S-79S.
30. Manca F, Carrozzi S, Kunkl A et al. Difference in sensitivity to cyclosporin in vitro of human alloreactive lines and clones. Transplantation 1986; 41: 199-203.
31. Muluk SC, Clerici M, Via CS et al. A new approach for analysis of the mixed lymphocyte reaction that is predictive for human renal allograft rejection. Transplant Proc 1991; 23: 1274-1276.
32. Clerici M, Shearer GM. Differential sensitivity of human T helper cell pathways by in vitro exposure to cyclosporin A. J Immunol 1990; 144: 2480-2485.
33. Roelen D, Datema G, Van Bree S et al. Evidence that antibody formation against a certain HLA alloantigen is associated not with a quantitative but in a qualitative change in the cytotoxic T cells recognizing the same antigen. Transplantation 1992; 53: 899-903.
34. Roelen DL, Van Beelen E. Van Bree SPMJ et al. The presence of activated donor HLA class I-reactive T lymphocytes is associated with rejection of corneal grafts. Transplantation 1995; 59: 1039-1042.
35. Ouwehand AJ, Baan CC, Roelen DL et al. The detection of cytotoxic T cells with high affinity receptors for donor antigens in the transplanted heart as prognostic factor for graft rejection. Transplantation 1993; 56: 1223-1229.
36. Viale M, Ferrini S, Bacigalupo A et al. Phenotypic and functional characterization of T cell clones following allogeneic bone marrow transplantation. Transplantation 1989; 47: 838-843.
37. Kabelitz D, Zanker B, Zanker C et al. Human cytotoxic T lymphocytes. II. Frequency analysis of cyclosporin A-sensitive alloreactive cytotoxic T-lymphocyte precursors. Immunology 1987; 61: 57-62.
38. + T cells differ in susceptibility to CsA-mediated inhibition of IL-2 production. Transplant Immunol (in press).